Tg(DMPK/tetO-EGFP/DMPK)5-313Masm
Transgene Detail
|
Symbol: |
Tg(DMPK/tetO-EGFP/DMPK)5-313Masm |
Name: |
transgene insertion 5-313, Mani S Mahadevan |
MGI ID: |
MGI:3813454 |
Synonyms: |
DM5, GFP-DMPK 3' UTR |
Transgene: |
Tg(DMPK/tetO-EGFP/DMPK)5-313Masm Location: unknown
|
Alliance: |
Tg(DMPK/tetO-EGFP/DMPK)5-313Masm page
|
|
|
Transgene Type: |
|
Transgenic (Humanized sequence, Inducible, Inserted expressed sequence, Reporter) |
Inducer: |
|
doxycycline/tetracycline |
Mutation: |
|
Insertion
|
|
|
Tg(DMPK/tetO-EGFP/DMPK)5-313Masm expresses
1 gene
Transgene expresses:
Organism |
Expressed Gene |
Homolog in Mouse |
Note |
human |
DMPK (1760) |
|
|
|
|
|
Mutation details: The human promoter was fused to seven copies of the tetracycline responsive element (TRE) to drive expression of the 5'UTR followed by an EGFP gene fused to the 3'UTR contained 5 CTG repeats and the first intron. The fusion product is expressed in accordance with the expression pattern of the endogenous promoter. Two lines were created (5-313 and 5-336).
(J:113088)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
Original: |
J:113088 Mahadevan MS, et al., Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy. Nat Genet. 2006 Sep;38(9):1066-70 |
All: |
8 reference(s) |
|